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Accurate predictions of functional outcome after limb salvage surgery (LSS) in the lower limb are important for several reasons,
including informing the patient preoperatively and, in some cases, deciding between amputation and LSS. This study aimed to
elucidate the correlation between surgeon-predicted and patient-reported functional outcome of LSS in the Netherlands. Twenty-
three patients (between sixmonths and ten years after surgery) and five independent orthopedic oncologists completed the Toronto
Extremity Salvage Score (TESS) and theRAND-36physical functioning subscale (RAND-36PFS).Theorthopedic oncologistsmade
their predictions based on case descriptions (including MRI scans) that reflected the preoperative status. The correlation between
patient-reported and surgeon-predicted functional outcome was “very poor” to “poor” on both scores (𝑟2 values ranged from 0.014
to 0.354). Patient-reported functional outcome was generally underestimated, by 8.7% on the TESS and 8.3% on the RAND-36 PFS.
Themost difficult and least difficult tasks on the RAND-36 PFSwere also themost difficult and least difficult to predict, respectively.
Most questions had a “poor” intersurgeon agreement. It was difficult to accurately predict the patient-reported functional outcome
of LSS. Surgeons’ ability to predict functional scores can be improved themost by focusing on accurately predictingmore demanding
tasks.
1. Introduction
Limb salvage surgery (LSS) rather than amputation is the
operation of choice in 70–85% of all malignant bone and soft
tissue lower limb sarcomas [1, 2]. Since the oncological results
for amputation and LSS in the surgical treatment of sarcomas
are comparable [3, 4], the decision to perform an amputation
or LSS is based on the tumor size, the tumor location, patient
preferences, the expected risk of complications and multiple
reoperations, and the expected functional outcome [3]. If it is
Hindawi Publishing Corporation
Sarcoma
Volume 2014, Article ID 436598, 11 pages
http://dx.doi.org/10.1155/2014/436598
2 Sarcoma
surgically possible, LSS is generally the preferred treatment,
unless a poor functional outcome is expected. It has been
shown that the functional outcome of LSS is superior to
amputation, with the exception of below-knee amputation,
which yields a similar function as limb salvage [5]. The
expected functional outcome of patients after LSS is thus an
important part of the preoperative decision making process
for the surgical treatment.
Several known predictors of functional outcome include
tumor size, location, grade, bone resection, muscle involve-
ment, use of radiotherapy, and motor nerve sacrifice [6]. The
functional outcome is predicted by the surgeon based on
these parameters combined with his/her clinical experience.
However, to the best of our knowledge, there are no reports
about how well surgeons are able to actually predict func-
tional outcome after LSS. Insight into the level of accuracy of
these predictions is important for several reasons. First, accu-
rate predictions of functional outcome are highly relevant
in informing the patient preoperatively about the expected
final functional outcome. Second, in some cases, the pre-
dictions are helpful in deciding between amputation or LSS.
Third, information about the correlation between predicted
functional outcome and patient-reported functional outcome
provides valuable information for surgeons in training.
In this study, (1)we aimed to establishwhether orthopedic
oncologists can accurately predict patient-reported func-
tional outcome of LSS in the treatment of sarcoma in the
lower limb in a selected group of patients. (2) We also exam-
ined whether there was a tendency to over- or underestimate
patient-reported functional outcome. Additionally, (3) we
sought to identify which items on the functional outcome
scores were least difficult and which were most difficult to
predict, and whether the surgeons agreed amongst them-
selves (interrater reliability) in their predictions.
2. Materials and Methods
2.1. Patients. We selected patients who had undergone a LSS
for a sarcoma in the lower limb from a database of ortho-
pedic oncologic patients at the Department of Orthopedic
Surgery of the Radboud University Medical Center (RUMC),
Nijmegen, The Netherlands. The database contained 216
patients who had undergone LSS or amputation for any type
of tumor in the hip or knee region.We selected patients using
the following inclusion criteria: follow-up at least six months
after the surgery (before July 1, 2012) for patients without
adjuvant treatment and at least twelve months for patients
with adjuvant treatment, a maximum follow-up of ten years
(after February 1, 2003), and age between 18–70 years, and
preoperative MRI scans had to be available. The follow-up
of at least six months was chosen because functional scores
tend to plateau within that time frame [6, 7]. We excluded
patients who had a bone tumor with an intact cortical bone,
as almost no functional deficits were expected to occur in
those patients. Patients who had suffered local recurrence
or complications that required reoperation in the last six
months before the study were excluded. A flow chart of the
patient selection is shown in Figure 1. Twenty-four patients
Original database
(n = 216)
No preoperative
MRI scan available
(n = 65)
Too young (n = 20)
Too old (n = 19)
Date of surgery
outside study range
(n = 10)
Tumor in the
bone, intact bone
cortex (n = 45)
Died (n = 22)
No limb-salvage
surgery (n = 7)
Recent (<6 months)
Suitable for
inclusion (n = 25)
Missing surgery
Could not be
contacted (n = 1)
Included (n = 23)
log (n = 1)
reresection (n = 3)
Figure 1: Flow chart of patient selection. Some patients fitted into
multiple exclusion criteria (e.g., “no preoperative MRI scan avail-
able” and “too old”); in such cases, the patientwas counted as belong-
ing to the first of those exclusion criteria.
were eligible for inclusion in the study, of whom 23 were
successfully contacted. All 23 patients were included in the
study. The study procedures were approved by the Local
Ethical Committee of the RUMC. Written informed consent
was obtained from all participants.
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2.2. Materials. To evaluate the functional outcome, we used
the Toronto Extremity Salvage Score (TESS) for the lower
extremity and the RAND-36 physical functioning subscale
(RAND-36 PFS). The TESS is a patient-reported question-
naire that has been specifically designed tomeasure the phys-
ical functional status of patients after limb-salvage surgery
[7]. It contains 30 questions, and the final score ranges from
0% to 100%, 100% being the highest achievable score. The
RAND-36 PFS is intended to measure physical functioning
in any patient cohort [8, 9], which makes it more general
than the TESS. Like the TESS, the RAND-36 PFS also is a
patient-reported questionnaire. The RAND-36 PFS consists
of ten questions, and the final score ranges from 0% to 100%,
100% being the highest achievable score. The RAND-36 PFS
is identical to the SF-36 PFS. In addition to the TESS and
RAND-36 PFS, we also used the RAND-36 pain subscale
to examine postoperative pain levels. The RAND-36 pain
subscale contains two questions; one regarding the amount
of pain and one regarding the hindrance experienced due
to pain when performing everyday activities in the previous
four weeks [8, 9]. The final score ranges from 0% to 100%,
where 100% represents no pain. We did not employ the
Musculoskeletal Tumor Society score [10], as that score is
not patient-reported and includes the domains of pain and
emotional acceptance, which would have been impossible to
predict solely on the basis of case descriptions.
A case description of each patient was made, which
reflected the preoperative status of the patient. It contained
the patient’s age, sex, body mass index (BMI), tumor diag-
nosis, diagnostic MRI scans, a description of the performed
surgical procedure for tumor resection and reconstruction,
whether the patient had received adjuvant pre- or postoper-
ative chemo- or radiotherapy, and whether there were any
complications from the surgery (a case example is shown
in Figure 2). The information did not include follow-up
time. If a reresection had been performed, the preoperative
MRI scans from before the primary resection surgery were
provided, rather than those made after the local recurrence.
The case descriptions were distributed through a central
electronic platform. Whenever bone was removed, it was
replaced by tumor prosthesis and/or an allograft.
2.3. Study Procedures. The patients were interviewed about
their current functional status in a structured telephone
call (done by KC, an independent researcher who was not
a medical doctor), consisting of the TESS, the RAND-36
PFS, and the RAND-36 pain subscale. Five independent
orthopedic oncologists (JB, PD, PJ, JP, and MvdS), working
in one of the other three Dutch orthopedic oncologic referral
centers (other than the RUMC) participated in the study.
They were asked to give a prediction of the total TESS score
(one percentage for the total functional status of the patient
without addressing all separate items) and a prediction of
the ten individual items of the RAND-36 PFS, based on
the case descriptions. They had never been involved in the
treatment of the patients and were unaware of their patient-
reported functional outcome. All orthopedic oncologists
were experienced and specialized in orthopedic oncology.
They were familiar with the employed functional scales and
were provided with a copy of the TESS questionnaire for
reference.
2.4. Outcome Measures and Statistical Analyses. Descriptive
statistics were calculated and stated as mean ± standard
deviation. We compared the patient-reported and surgeon-
predicted TESS and RAND-36 PFS scores in three ways.
First, Pearson correlations were calculated between the
patients’ reported scores and individual surgeon predicted
scores, as well as for the average scores of all the surgeons
combined.The squared correlation coefficient, 𝑟2, (coefficient
of determination), represents the variation in the values of the
patient-reported outcome that can be explained by variations
in the value of the surgeon-predicted outcome [11]. An 𝑟2-
value of 0.75–1.00was interpreted as a “very good” prediction,
0.50–0.74 as “good,” 0.25–0.49 as “poor,” and 0-0.24 as “very
poor.” The 𝑟2-values were considered the primary outcome
measure.
Second, the mean differences and 95% confidence inter-
vals (95% CI) between the patient-reported scores on the
TESS and RAND-36 PFS and the surgeon-predicted scores
were calculated to reveal whether the predictions had a bias
towards being too optimistic or pessimistic.
Third, the agreement between patient-reported and the
median surgeon-predicted answers to the separate questions
of theRAND-36PFSwere examinedusing percent agreement
and Gwet’s agreement coefficient (AC1). Compared with
Cohen’sKappa [12, 13],Gwet’sAC1 has amore stable interrater
reliability and is less affected by prevalence and marginal
probability [14]. This allowed us to identify which questions
were the least difficult and most difficult to predict. The
intersurgeon agreement on each separate question was also
calculated, using percent agreement and Gwet’s AC1. To cal-
culate the intersurgeon agreement on the TESS, we used the
intraclass correlation coefficient (ICC; absolute single mea-
sure/absolute agreement). Agreement coefficients below 0.40
were considered to represent a “poor” agreement; between
0.40 and 0.59 “fair”; between 0.60 and 0.74 “good”; and
between 0.75 and 1.00 “excellent,” analogous to commonly
used guidelines for interexaminer agreement [15].
The associations between each separate variable (age, sex,
BMI, pain, and time since surgery) and patient-reported
TESS and RAND-36 were examined using univariate regres-
sion analyses to examine whether they were associated with
the functional outcome scores.
Matlab R2011a (TheMathworks, Natick, MA, USA) and R
version 3.0.2. [16] were used for the statistical analyses.
3. Results
3.1. Patients. The characteristics of all 23 patients are listed in
Table 1. The age at the time of surgery was 39.9 ± 18.8 years
and the time after surgery was 47 ± 27 months. All patients
were ambulatory and able to at least walk short distances
without a walking aid. Two patients (cases 10 and 21) had
undergone a reresection; this was mentioned in the case file.
All other patients had not suffered from local recurrence
4 Sarcoma
Case 7: ♂ 37 years
Malignant fibrous hystiocytoma
left distal femur, pretreated with chemotherapy. 
An incision biopsy has been done on the left
anterolateral side.
BMI: 23,74 (83kg/1m872)
Indication:
Top row: transversal (T1-FS)
Middle row: transversal (T1)
Bottom row: sagittal (T1)
Preoperative MRI:
Reconstruction Extra-articular distal femur
resection and reconstruction with tumour
Surgical treatment:
prosthesis.
Figure 2: Example case as given to the orthopedic oncologists. This is patient 7 in Table 1.
or complications that required follow-up surgery. The mean
patient-reported scores were TESS 87.0±12.1, RAND-36 PFS
73.3 ± 18.7, and RAND-36 pain subscale 85.5 ± 24.7.
3.2. Surgeon Predictions—TESS. The surgeon-predicted scores
and their correlations with the patient-reported scores of
all five surgeons and the average predictions of all surgeons
on the TESS are shown in Figure 3 and in Table 2. The
correlations with the patient-reported scores were “very
poor” for all surgeons, with the best correlation for surgeon 2
(𝑟2 = 0.185). The TESS was underestimated for most patient
cases (Figure 3); the mean underestimation ranged from 1.5
to 22.6 percentage points (Table 2). The correlations with the
patient-reported TESS formed by averaging all five surgeons’
predictions were “very poor” (𝑟2 = 0.159) and underesti-
mated patient-reported functional outcome by 8.7 (95% CI:
3.62–13.7) percentage points. The intersurgeon agreement on
the TESS was “poor” with an ICC of 0.29 (95% CI: 0.10–
0.53).
3.3. Surgeon Predictions—RAND-36 PFS. The surgeon-pre-
dicted RAND-36 PFS scores and their correlations with the
patient-reported scores are shown in Figure 4 and in Table 2.
The correlations to the patient-reported scores were either
“very poor” (surgeons 1, 4, and 5) or “poor” (surgeons 2
and 3). Surgeon 3’s predictions had the highest correlation
with the patient-reported scores (𝑟2 = 0.354). The patient-
reported RAND-36 PFS score was underestimated by all
surgeons, except for surgeon 2 (5.4 percentage points overes-
timation) (Table 2).The average correlationswith the patient-
reported scores were “poor” (𝑟2 = 0.255) and underestimated
patient-reported functional outcome by 8.3 (95% CI: 0.64–
16.0) percentage points.
In the analysis of the individual questions that make
up the RAND-36 PFS, “Climbing several flights of stairs”
and “Walking more than a mile” were the most difficult
items to predict, with “poor” agreement coefficients (AC1)
of 0.15 and 0.19, respectively, between surgeon-predicted and
patient-reported scores (Table 3). “Walking one block” and
“Bathing or dressing yourself ” were the least difficult items to
predict, with “excellent” agreement coefficients of 0.81 and
0.76, respectively, between surgeon-predicted and patient-
reported scores. Similar to the overall RAND-36 PFS scores,
most of its separate questions were underestimated; only
two questions were overestimated (“Bending, kneeling, or
stooping” and “Lift-ing or carrying groceries”).
Onmost questions of theRAND-36PFS, the intersurgeon
agreement coefficient was “poor,” but there was a “fair” agree-
ment on “Bathing or dressing yourself ” and “Moderate activ-
ities” and a “good” agreement on “Vigorous activities” and
“Walking one block” (Table 3).
3.4. Other Potential Predictors. No correlations were found
between the TESS or RAND-36 PFS and any of the potential
predicting factors (Table 4).
4. Discussion
Thisnational survey aimed to investigate howwell orthopedic
oncologists are able to predict the patient-reported functional
outcome of patients that had undergone LSS in the lower
limb. We found “very poor” to “poor” correlations between
patient-reported outcomes and surgeon-predicted outcomes
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Figure 3: Scatter plots of patient-reported outcome and orthopedic tumor surgeon predictions on the Toronto Extremity Salvage Scale
(TESS).The dashed lines indicate a hypothetical perfect correlation; if a patient case lies above or below this line, the functional outcome was
overestimated or underestimated, respectively.
Table 2: Patient-reported and surgeon-predicted mean TESS and
RAND-36 PFS scores and coefficients of determination for TESS
and RAND-36 PFS scores.
TESS RAND-36 PFS
Mean scorea 𝑟2 Mean scorea 𝑟2
Patient-reported 87.0 (12.1) 73.3 (18.7)
Surgeon 1 75.6 (13.6) 0.167 50.9 (20.3) 0.142
Surgeon 2 83.6 (8.6) 0.185 78.7 (15.5) 0.336
Surgeon 3 82.5 (7.1) 0.096 70.2 (17.9) 0.354
Surgeon 4 85.5 (11.9) 0.014 72.2 (18.7) 0.081
Surgeon 5 64.3 (14.7) 0.088 52.8 (26.8) 0.118
Average of surgeons 78.3 (8.7) 0.159 65.0 (16.6) 0.255
aScores are reported as mean (SD).
on both the TESS and the RAND-36 PFS. The orthopedic
oncologists tended to underestimate patient-reported func-
tional outcome on both scales. The most difficult tasks on
the RAND-36 PFS were also the most difficult to predict,
whereas, for the least difficult tasks, it was easy to predict
that these could be performed without substantial limitations
by nearly all patients. The intersurgeon agreement on the
RAND-36 PFS questions was mostly “poor” but was “good”
for some of the most and least demanding tasks. None of
the potentially predicting factors were related to the primary
outcome measures.
Our results indicate that it was difficult for the participat-
ing orthopedic oncologists to accurately predict the patient-
reported functional outcome of limb salvage surgery. On
the TESS, for instance, the coefficients of determination (𝑟2)
between patient-reported and surgeon-predicted outcomes
were lower than 0.20, indicating that less than 20% of the
variance in TESS could be explained by the predictions made
by the orthopedic oncologists. We did not expect such a
poor predictive ability, considering the experience level of
the orthopedic oncologists with limb salvage surgery. Several
aspects may underlie this seemingly rather poor predictive
ability.
First, each limb salvage patient presents a unique case
in terms of anatomical involvement. Even in patients with
the same type of tumor at a similar location, for instance,
the distal femur, final functional results can differ to a large
extent. In part, this depends on the amount and precise
location of soft tissue involvement, which may have been
difficult to see from the limited set of MRI images in the
case files. Moreover, patients are unique in terms of adaptive
capacity. The adaptation of the patient to the new anatomical
and sensorimotor situation plays a large role in the recovery of
function [17].The amount of adaptive capacitymay have been
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Figure 4: Scatter plots of patient-reported outcome and orthopedic tumor surgeon predictions on the RAND-36 physical functioning
subscale (RAND-36 PFS). The dashed lines indicate a hypothetical perfect correlation; if a patient case lies above or below this line, the
functional outcome was overestimated or underestimated, respectively.
hard or impossible to estimate by the orthopedic oncologists
from the case files. Second, we measured functional outcome
with questionnaires, which are inherently subjective. Thus,
the patients’ own perception of functioning may have played
a large role in the functional outcome score. It might be that
functional outcomemeasured by objectivemeans, such as, for
example, gait analysis, more closely reflects the orthopedic
oncologists’ predictions. Third, in the case files, we mim-
icked as well as possible the information typically available
preoperatively to the surgeon in a clinical setting, but the
study design did not permit the independent surgeons to
review the medical history of the patients nor perform a
physical examination before the surgery. As such, predictions
of patient-reported functional outcome in a “real” clinical
setting (e.g., including a physical examination)might bemore
accurate than those made in this study. Fourth, patients who
had a bone tumor with an intact cortical bone were not
included; the patient-reported functional outcome in those
patients would potentially have been less difficult to predict
than that in the patients with larger tumors.
The poor predictive ability raises the question of which
other factors determine functional outcome in limb saving
surgery and to what degree. Davis et al. showed that large
tumor size, deep lesions, high grade tumor, use of radi-
otherapy, bone resection, and motor nerve sacrifice are
significantly related to increased disability on the TESS [6]. In
their study, those combined parameters were able to predict
20% of the variance in TESS score. This is in the same order
ofmagnitude as the presently reported results, indicating that
the surgeons were unable to “add” predictive value on top
of the given parameters in the case files. The rehabilitation
protocol may also have an effect on functional outcome; She-
hadeh et al. showed that adherence to a strict rehabilitation
protocol after limb salvage surgery led to a relatively high level
of functional outcome compared with other studies [18]. If
we interpret our findings concurrent with those of Davis et
al. and Shehadeh et al., it appears that still a large percentage
of functional outcome cannot be predicted by the surgeon
nor by anatomical and surgery or adjuvant therapy-related
factors nor by rehabilitation protocols. Other factors that
may play a significant role in the patient-reported functional
outcome include the preoperative physical and mental state
of the patient. For example, a patient who is highly motivated
and athletic may recover to a far higher level of functioning
than one who is less motivated and leads a sedentary lifestyle.
From this perspective, one may intuitively expect a correla-
tion between patient-reported functional outcome and age
or BMI, but we did not find this (Table 4). Further studies
are required to clarify the role each factor plays in patient-
reported functional outcome after limb salvage surgery.
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Table 4: Coefficients of determination between patient character-
istics and functional outcomes (TESS and RAND-36 physical func-
tioning subscale).
TESS RAND-36 PFS
𝑟
2
𝑟
2
Age 0.011 0.001
Sex 0.024 0.001
Body mass index 0.008 0.003
Pain (RAND-36 pain subscale) 0.042 0.079
Time since surgery 0.036 0.015
The orthopedic oncologists tended to underestimate
patient-reported functional outcome on both the TESS and
the RAND-36 PFS. Thus, it appears that the patients adapted
to the new anatomical and functional situation better than
the surgeons predicted. It is possible that this is due to some
surgeons being used to picturing a somewhat more pes-
simistic scenario to their patients so that the actual achieved
functional result exceeds the patients’ expectations. However,
we specifically instructed the surgeons to provide their most
accurate predictions of patient-reported functional outcome,
rather than to provide predictions that they would share with
patients. As for clinical relevance, we did not set a specific
threshold, but the underestimation of patient-reported func-
tional outcome on both the TESS and the RAND-36 PFS
was rather consistent, as demonstrated by the 95% confidence
intervals that did not pass through zero.
Interestingly, we found that the “Walking one block” ques-
tion was the least difficult to predict, whereas the “Walking
more than amile” question was one of themost difficult ques-
tions to predict (only “Climbing several flights of stairs” was
more difficult to predict). It appears that the ultimate level of
function that is reached in patients is hard to predict, whereas
it is easier to predict lower levels of function. Thus, surgeons’
ability to predict functional scores can be improved the
most by focusing on accurately predicting more demanding
tasks. Additional improvement might be gained by analyzing
the prediction for the “Bending, kneeling, or stooping” ques-
tion. If the prediction for this question did not match with
the patient-reported outcome, it was mostly overestimated
(43.5% of cases). This overestimation breaks with the general
trend to underestimate patient-reported functional outcome
and indicates that bending the knees is more difficult to do
for patients than the median surgeon predicted.
The intersurgeon agreement on most RAND-36 PFS
questions was “poor,” indicating that there was a high inter-
surgeon variability in the predictions to the questions. Nota-
ble exceptions were “Walking one block” and “Vigorous activi-
ties,” with “good” intersurgeon agreement.The prior arguably
is the least difficult activity on the scale, whereas the latter
represents themost demanding activities on the scale (includ-
ing running, heavy lifting, and strenuous sports). However,
this does not imply that there was also a high agreement with
the patient-reported outcome; “Vigorous activities” had only
a “fair” agreement with the patient-reported score. “Walking
one block,” on the other hand, was the only question that had
both an “excellent” agreementwith the patient-reported score
as well as a “good” intersurgeon agreement. This might be
due to the surgeons’ familiarity with predicting this basic level
of functional outcome or because being able to walk at least
short distances is considered one of the criteria for attempting
limb salvage surgery, and most patients indeed achieved that
goal.
This study has some limitations. First, the surgeons only
predicted the total TESS score, instead of predicting each
of the 30 questions that comprise the score. This was done
because some questions were already present in the much
shorter RAND-36 PFS, and to reduce the time it would take
the surgeons to predict the 23 cases. Second, we used a
translated version of theTESSwhich has not been validated in
Dutch. However, as the TESS is the gold standard assessment
tool after limb salvage surgery, we decided to use it [19]. The
RAND-36 PFS has been validated in Dutch [8, 9], and its
results showed the same trend in the comparisons as the
translated TESS. Third, we found a wide range of patient-
reported functional outcome scores, including in patients
that had undergone similar surgery. Of course, each case
is unique, but the perception of effort required to perform
the activities in the questionnaires and the interpretation of
the questions can vary between patients. Measuring actual
functional outcome (e.g., in a movement laboratory or by
observing patients in their home setting) could yield more
knowledge of actual functioning, eliminate the subjectiv-
ity inherent in questionnaires, and establish the construct
validity of the employed functional scoring systems. Fourth,
the surgeons predicted the functional outcome based on a
case description without being allowed to review the medical
history of the patients or perform a physical examination.
The time since surgery was also not provided, which might
have negatively affected the predictions. This, however, does
not explain the large differences found between predicted and
patient-reported functional outcome nor does it explain the
differences in predictions between surgeons. Furthermore,
there was no correlation between the patient-reported func-
tional scores and the time since surgery (Table 4).
5. Conclusions
It was difficult for the participating orthopedic oncologists to
accurately predict the patient-reported functional outcome
of limb salvage surgery. Patient-reported functional outcome
tended to recover to a higher level than the surgeons pre-
dicted.Theultimate level of function that the patients reached
was hard to predict, whereas it was easier to predict lower
levels of function.Thus, surgeons’ ability to predict functional
scores can be improved the most by focusing on accurately
predictingmore demanding tasks. Intersurgeon agreement to
most questions was “poor,” indicating the high variability in
the surgeons’ predictions, and, possibly, treatment decisions.
The poor predicting ability warrants research into objective
tools to assist orthopedic oncologists in the decision making
process. Such tools could include, for instance, computational
musculoskeletal models that prospectively calculate whether
enoughmuscle strength remains to perform activities of daily
living.
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